Trial Site Detail
Drug: |
Nilotinib or Imatinib |
|||
|---|---|---|---|---|
Trial: |
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
|||
CHUS - Hospital Fleurimont |
Principal Investigator: |
Rami Kotb, MD |
|---|---|
Contact: |
Brigitte Jean 1-819-346-1110 ext. 12872 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
CHUS - Hospital Fleurimont Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.